Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

2010

3645 ARTíCULOS , VIENDO DEL 31 AL 45

PUBMED

Improvement. Asthma and Parkinson's lose out in policy battle.

West D.

Health Serv J. 2010 Apr 22;120(6203):7. No abstract available.

0

0

0

PUBMED

L-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia.

Lindgren HS, Andersson DR, Lagerkvist S, Nissbrandt H, Cenci MA.

J Neurochem. 2010 Mar;112(6):1465-76. doi: 10.1111/j.1471-4159.2009.06556.x.

0

0

0

PUBMED

Anxiety disorders in Parkinson's disease: prevalence and risk factors.

Dissanayaka NN, Sellbach A, Matheson S, O'Sullivan JD, Silburn PA, Byrne GJ, Marsh R, Mellick GD.

Mov Disord. 2010 May 15;25(7):838-45. doi: 10.1002/mds.22833.

0

0

0

PUBMED

High-frequency stimulation of the subthalamic nucleus restores neural and behavioral functions during reaction time task in a rat model of Parkinson's disease.

Li XH, Wang JY, Gao G, Chang JY, Woodward DJ, Luo F.

J Neurosci Res. 2010 May 15;88(7):1510-21. doi: 10.1002/jnr.22313.

0

0

0

PUBMED

[Neuroimaging in Parkinson's disease].

Hilker R, Steinmetz H.

Nervenarzt. 2010 Oct;81(10):1159. doi: 10.1007/s00115-010-3021-9. German. No abstract available.

0

0

0

PUBMED

Caregiver education in Parkinson's disease: formative evaluation of a standardized program in seven European countries.

A'Campo LE, Spliethoff-Kamminga NG, Macht M; EduPark Consortium., Roos RA.

Qual Life Res. 2010 Feb;19(1):55-64. doi: 10.1007/s11136-009-9559-y.

0

0

0

PUBMED

Neurogenic orthostatic hypotension of Parkinson's disease: what exploration for what treatment?

Senard JM, Pathak A.

Rev Neurol (Paris). 2010 Oct;166(10):779-84. doi: 10.1016/j.neurol.2010.07.007. Review.

0

0

0

PUBMED

Cognitive improvement after duodenal levodopa infusion in cognitively impaired Parkinson's disease patients.

Sánchez-Castañeda C, Campdelacreu J, Miró J, Juncadella M, Jaumà S, Calopa M.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):250-1. doi: 10.1016/j.pnpbp.2009.10.021. No abstract available.

0

0

0

PUBMED

Four novel mutations in the GCH1 gene of Chinese patients with dopa-responsive dystonia.

Cao L, Zheng L, Tang WG, Xiao Q, Zhang T, Tang HD, He SB, Wang XJ, Ding JQ, Chen SD.

Mov Disord. 2010 Apr 30;25(6):755-60. doi: 10.1002/mds.22646.

0

0

0

PUBMED

Premorbid combat related ptsd in Huntington's disease - Case report.

Skocić M, Dujmović J, Jevtović S, Jakovljević M.

Psychiatr Danub. 2010 Jun;22(2):286-8.

0

0

0

PUBMED

Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington's disease.

Thu DC, Oorschot DE, Tippett LJ, Nana AL, Hogg VM, Synek BJ, Luthi-Carter R, Waldvogel HJ, Faull RL.

Brain. 2010 Apr;133(Pt 4):1094-110. doi: 10.1093/brain/awq047.

0

0

0

PUBMED

Fall risk assessment using the Tinetti mobility test in individuals with Huntington's disease.

Kloos AD, Kegelmeyer DA, Young GS, Kostyk SK.

Mov Disord. 2010 Dec 15;25(16):2838-44. doi: 10.1002/mds.23421.

0

0

0

PUBMED

Evaluation of IP-RP-HPLC for length determination of the trinucleotide repeat fragments in Huntington's disease.

Skrzypczak M, Heinritz W, Schulz AM, Mierzejewski M, Froster UG.

J Chromatogr Sci. 2010 Jan;48(1):55-8.

0

0

0

PUBMED

Neuroleptic malignant syndrome with aripiprazole in Huntington's disease.

Gahr M, Orth M, Abler B.

Mov Disord. 2010 Oct 30;25(14):2475-6. doi: 10.1002/mds.23332. No abstract available.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy